Alteraciones endocrinometabólicas en la enfermedad pulmonar obstructiva crónica

Torres-Sánchez, Irene; Valenza, Marie Carmen; Carrasco, Fernando; Cabrera-Martos, Irene; Valenza-Demet, Gerald; Cano-Capellaci, Marcelo
July 2013
Nutricion Hospitalaria;jul/ago2013, Vol. 28 Issue 4, p1022
Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by the presence of chronic airflow obstruction and associated endocrinometabolic disorders, which usually worsen the clinic and prognostic of the patients. Therefore, in-depth knowledge of these prevalent disorders in patients with COPD is relevant to develop preventive measures and early detection. Purpose: To analyze the prevalence of endocrinometabolic diseases that occur in COPD subjects and their related risk factors. Methods: We carried out a bibliographic search of the bibliographic resources of the last 10 years, including PubMed, Scopus and ScienceDirect databases. Words used were: “endocrine metabolic disorders AND COPD", “endocrine disorders AND COPD" and “metabolic disorders AND COPD". The bibliographical analysis was made in two steps. During the first phase, we excluded those articles in which the title or their content did not correspond with the objective settled; during the second phase, we deleted all the references duplicated in both databases. Finally, 17 articles after full-text critical appraisal were maintained. Results: After reviewing the articles, we found a significant relationship between diabetes mellitus, metabolic syndrome, obesity, osteoporosis, hypogonadism and COPD. Different authors have reported a higher prevalence of these comorbidities, influencing the development of COPD. Conclusions: Due to the high prevalence and association with COPD, these comorbidities have to be considered by the health professionals related to the COPD patients. Better understanding of the endocrinometabolic disorders related to COPD can influence the treatment and the outcome of patients.


Related Articles

  • Inferring the quality of hospital treatment for COPD by mortality; caution is needed. Morgan, M. D. L. // Thorax;Oct2013, Vol. 68 Issue 10, p897 

    The article offers information on the treatment for Chronic obstructive pulmonary disease (COPD) by mortality and its impact on the quality of the hospitals. It mentions that in hospital care of COPD patients admitted with acute exacerbation would result in a reduction of mortality. It informs...

  • Fluticasone/salmeterol is associated with a higher risk of pneumonia and pneumonia related events in comparison with budesonide/formoterol in patients with COPD. Jabbar, Avais // Thorax;Nov2013, Vol. 68 Issue 11, p996 

    In this article, the author reflects on a PATHOS study related to the association of combined drug treatment process with fluticasone and salmeterol with higher risks of pneumonia and compares the impact of budesonide and formoterol on patients with chronic obstructive pulmonary disease (COPD)...

  • Should we give long-term macrolide therapy for COPD? Crosbie, Philip A. J.; Woodhead, Mark; Albert, Richard K. // Thorax;Oct2013, Vol. 68 Issue 10, p966 

    In this article, the authors debate on the topic related to the macrolide therapy in patients with chronic obstructive pulmonary disease (COPD). They reported that low-dose macrolides for exacerbation prevention, should not be recommended in the management of COPD. They informed that macrolides...

  • Breathe Easy: Living Well with COPD.  // Washington Informer;4/2/2015, Vol. 50 Issue 25, p21 

    The article discusses the effects of the Chronic Obstructive Pulmonary Disease (COPD) on humans, its symptoms and risk factors, and treatment which involves avoiding first- and secondhand smoke, mold and dust.

  • Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease? YASAR, Z.; BUYUKSIRIN, M.; UCSULAR, F. D.; KARGI, A.; ERDEM, F.; TALAY, F.; KURT, O. K. // European Review for Medical & Pharmacological Sciences;Mar2015, Vol. 19 Issue 6, p956 

    OBJECTIVE: This study aimed to evaluate the diagnostic value of the neutrophil-to-lymphocyte ratio (NLR) in early detection of metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS:We retrospectively enrolled hospital records of 140 COPD...

  • First COPD guide promotes shots, better management. Marselas, Kimberly // McKnight's Long-Term Care News;Dec2014, Vol. 35 Issue 12, p6 

    The article discusses the guidelines by American College of Chest Physicians and the Canadian Thoracic Society for the patients with chronic obstructive pulmonary disease having the increased risk of exacerbations and to use the pneumococcal and flu vaccines for the better management of disease.

  • Risk factors for chronic obstructive pulmonary disease: Results of the FARIECE study. de Córdova-Aguirre, J. C. Fernández; Guzmán-Guillen, K. A.; Álvarez-Serrano, M. E.; Vintimilla-Maldonado, J. R. // Revista Medica del Hospital General de Mexico;2015, Vol. 78 Issue 4, p162 

    Introduction: Although smoking is the main risk factor, it is not the only one. Current medical evidence shows that airflow limitation also develops for other reasons. Objective: Our main objective was to determine risk factors which are associated with chronic pulmonary disease, among patients...

  • Women More Likely than Men to Have COPD--and Many Are Undiagnosed.  // Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p3 

    The article focuses on the increased risk of chronic obstructive pulmonary disease (COPD) in women which is identified as emphysema and chronic bronchitis. It states that reports from the health organization American Lung Association have shown the increased risk of lung damage by cigarette...

  • Lung Function Response to 12-week Treatment with Combined Inhalation of Long-acting β2 Agonist and Glucocorticoid According to ADRB2 Polymorphism in Patients with Chronic Obstructive Pulmonary Disease. Woo Jin Kim; Yeon-Mok Oh; Joohon Sung; Tae-Hyung Kim; Jin Won Huh; Hoon Jung; Ji-Hyun Lee; Eun-Kyung Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Sung-Youn Kwon; Sang Do Lee // Lung;Nov2008, Vol. 186 Issue 6, p381 

    Recent reports suggest that β2-adrenergic receptor ( ADRB2) genotypes are associated with therapeutic responses to β2 agonists in asthmatics. However, few studies have investigated therapeutic responses to β2 agonists in chronic obstructive pulmonary disease (COPD) patients. This study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics